Ownership and insider activity for Prenetics Global Limited (PRE): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health reports based on sequencing technology.
Price
| Price | $24.19 |
| Market Cap | $411M |
| Exchange | NASDAQ |
| Country | HK |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-04 | Leogrande Hudson Blake | M-Exempt | 2,000 | |
| 2026-09-04 | Leogrande Hudson Blake | M-Exempt | 2,000 | |
| 2026-09-03 | Tat Thuan Yen | A-Award | 10,730 | |
| 2026-08-25 | Rosin Brian J | P-Purchase | 5,100 | $116K |
| 2026-08-24 | Rosin Brian J | P-Purchase | 18,000 | $381K |
| 2026-08-17 | Levy Caroline S | 7,595 | ||
| 2026-08-21 | Lo Hoi Chun | M-Exempt | 32,736 | $3 |
| 2026-08-21 | Lo Hoi Chun | M-Exempt | 45,815 | |
| 2026-08-21 | Lo Hoi Chun | M-Exempt | 45,815 | |
| 2026-08-21 | Lo Hoi Chun | M-Exempt | 491,029 | $49 |
Balance Sheet (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.5M | $14.5M | $35.3M | $146.7M | $45.7M | $52.3M | $32.1M |
| Short-term Investments | $294064 | $314715 | $9.9M | $37.5M | $27.0M | $10.6M | $29.4M |
| Receivables | $2.9M | $23.1M | $47.1M | $42.5M | $5.3M | $5.6M | $3.0M |
| Inventory | $547854 | $4.5M | $6.8M | $4.5M | $3.1M | $6.6M | $7.1M |
| Total Current Assets | $15.6M | $44.0M | $106.9M | $241.8M | $93.7M | $86.1M | $83.4M |
| Property, Plant & Equipment | $2.1M | $4.7M | $13.0M | $13.1M | $5.8M | $7.8M | $1.8M |
| Goodwill | $3.9M | $4.0M | $4.0M | $33.8M | $29.2M | $37.4M | 0 |
| Intangible Assets | $6.3M | $24.0M | $23.8M | $14.8M | $13.4M | $11.6M | $44.7M |
| Total Assets | $29.7M | $78.9M | $148.5M | $312.1M | $254.2M | $213.6M | $203.5M |
| Accounts Payable | $2.8M | $13.4M | $10.0M | $7.3M | $1.7M | $3.7M | $7.7M |
| Short-term Debt | 0 | $15.5M | $1.7M | 0 | 0 | 0 | $1.3M |
| Total Current Liabilities | $11.9M | $47.1M | $58.7M | $57.2M | $39.5M | $36.6M | $27.7M |
| Long-term Debt | $124320 | 0 | $486.4M | 0 | 0 | 0 | $437000 |
| Total Liabilities | $12.8M | $47.9M | $549.4M | $68.7M | $44.0M | $42.2M | $29.0M |
| Retained Earnings | -$41.6M | -$43.6M | 0 | -$408.0M | -$470.8M | -$517.1M | 0 |
| Total Equity | $16.9M | $31.1M | -$400.8M | $237.1M | $206.4M | $170.4M | $174.6M |
| Total Debt | $1.5M | $17.1M | $491.7M | $6.6M | $2.4M | $5.8M | $2.2M |
| Net Debt | -$10.4M | $2.3M | $446.5M | -$177.5M | -$70.4M | -$57.0M | -$59.3M |
| Working Capital | $3.7M | -$3.1M | $48.2M | $184.6M | $54.2M | $49.6M | $55.7M |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 4.04 |
Profitability
| Return on Equity | -49.17% |
| Return on Invested Capital | -42.66% |
| Return on Assets | -44.00% |
| Gross Margin | 62.61% |
| Operating Margin | -35.20% |
| Net Margin | -47.43% |
Related companies: ARMP · ATLN · CDXS · IMDX · MXCT · OSUR · PROF
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of PRE: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks